Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone ...Middle East

Medscape - News
Men with metastatic disease who received enzalutamide demonstrated a small but significant survival benefit. The study was published as a preprint and has not yet been peer reviewed. Medscape Medical News

Hence then, the article about prostate cancer survival enzalutamide edges out abiraterone was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News